AXOL BIOSCIENCE LTD.

In News

Axol Bioscience Raises $2.8M to Advance US Expansion and Product Development - Business Wire

Business Wire - Jan 13, 2026

Venture Capital Funding Flowing into the iPSC Sector by Year - BioInformant

BioInformant - Aug 03, 2025

Axol Bioscience to expand in Edinburgh after $2.8m funding deal - Scottish Financial News

Scottish Financial News - Jan 14, 2026

Validation of a cortical tri-culture axoModel™ for in vitro compound screening: A blinded compound study - News-Medical

News-Medical - Nov 18, 2024

Axol Bioscience introduces CiPA-validated human stem cell-derived ventricular cardiomyocytes to help improve drug discovery - the-scientist.com

the-scientist.com - Aug 02, 2022

Axol Bioscience Acquires Phenocell to Advance Human Disease Models - Business Wire

Business Wire - Oct 21, 2024

Axol Bioscience Ltd : Quotes, Address, Contact - News-Medical

News-Medical - Sep 07, 2018

eBook: Using iPSCs models for human disease research and drug discovery - News-Medical

News-Medical - Aug 30, 2024

axoCells™: Functional iPSC-derived Microglia for neuroinflammatory drug discovery - News-Medical

News-Medical - May 09, 2024

Advanced Cardiotoxicity Testing Using Multi-Channel iPSC Cardiomyocytes - News-Medical

News-Medical - Sep 20, 2024

Using human iPSC-derived cells to revolutionize the field of neurodegenerative disease - News-Medical

News-Medical - Nov 28, 2022

axoCells™ : Functional human iPSC-derived Sensory Neurons for drug discovery and research - News-Medical

News-Medical - May 09, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment